Lysosomal Therapeutics
United States · $24.8M raised
- Business Model
- B2B
- Website
- lysosomaltx.org
- Total Funding
- $24.8M
- Last Round
- $20.0M Series AFeb 2015
- Rounds
- 2
About
Novel therapies for neurodegenerative diseases
Summary
Lysosomal Therapeutics is a Biotech company based in United States. It has raised $24.8M in total across 2 rounds, most recently a $20.0M Series A round in Feb 2015. Investors include Atlas Venture, Hatteras Venture Partners and Sanofi Ventures.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2015
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company